Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2300068632Phase 4Recruiting
Phase 4, randomised trial in postoperative delirium (POD) comparing Remimazolam arm with Propofol arm (2 arms). Primary endpoint: Incidence of postoperative delirium. Started Mar 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2300068632.